ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® Portfolio
July 13, 2021Inotiv acquired genetic toxicology assets from MilliporeSigma’s BioReliance® portfolio, including standard operating procedures, stock cultures, historic control data and client list. -
BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program
March 19, 2021BioVaxys Technology Corp., the world leader in haptenized protein vaccines for antiviral and cancer applications, announced that it has entered into an agreement with Bioanalytical Systems, Inc. d/b/a Inotiv, a global Contract Research Organization ...
Pharma Sources Insight January 2025
